In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Axaron Bioscience AG

Division of Sygnis AG

Latest From Axaron Bioscience AG

Deals Shaping the Medical Industry (9/06)

The dealmaking column is a survey of recent transactions, including strategic alliances, mergers & acquisitions, and financings, in the life sciences industries. Deals are listed by the following industry sectors: in vitro diagnostics, pharmaceuticals, medical devices, and research/analytical instrumentation and reagents. All transactions are excerpted from Windhover's Strategic Transactions database, providing comprehensive transaction coverage from 1991 to the present.

The Norway Loophole

Cambridge Antibody Technology has built a business based on an exclusive license to a key biotech patent on antibody expression libraries. But the patent holder, Medical Research Council, neglected to file for a patent in Norway. Enter Affitech, which has taken advantage of the loophole to obtain a patent on a more efficient way of creating and screening phage-derived antibody libraries and in the process creating new competition for CAT. Although Affitech can't sell the antibodies it screens outside of Norway, it claims it can legally sell optimized, already screened antibodies to anyone who wants them. And it believes it has an eager customer base.
BioPharmaceutical Europe
See All

Company Information

  • Industry
  • Biotechnology
  • Pharmaceuticals
  • Therapeutic Areas
  • Neurology, Nervous System
  • Alias(es)
  • Ownership
  • Private
  • Headquarters
  • Worldwide
    • Europe
      • Western Europe
        • Germany
  • Parent & Subsidiaries
  • Sygnis AG
  • Senior Management
  • Alfred Bach, PhD, CEO
  • Contact Info
  • Axaron Bioscience AG
    Phone: (49) 6221 454 6
    Im-Neuenheimer, Feld 515
    Heidelberg, 69120